CXCL8 and COVID-19: Elevated concentrations of immune-derived markers of systemic inflammation, such as tumour necrosis factor-α (TNF-α), interleukin-6 (IL-6) and interleukin-8 (IL-8), have been observed up to 40 days after COVID-19.